• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质膜成分调节扁柏酚对角质形成细胞和成纤维细胞的作用。

Lipid membrane composition modulates Hinokitiol's effects on keratinocytes and fibroblasts.

作者信息

Wyżga Beata, Kamiński Kamil, Głowacka Kinga, Hąc-Wydro Katarzyna

机构信息

Jagiellonian University, Faculty of Chemistry, Gronostajowa 2, Kraków 30-387, Poland; Jagiellonian University, Doctoral School of Exact and Natural Sciences, Łojasiewicza 11, Kraków 30-348, Poland.

Jagiellonian University, Faculty of Chemistry, Gronostajowa 2, Kraków 30-387, Poland.

出版信息

Chem Phys Lipids. 2025 Aug;270:105511. doi: 10.1016/j.chemphyslip.2025.105511. Epub 2025 Jun 11.

DOI:10.1016/j.chemphyslip.2025.105511
PMID:40513700
Abstract

Hinokitiol (β-thujaplicin) is a natural antimicrobial agent used in cosmetics. The aim of presented studies was to gain insight into the interactions of hinokitiol with lipids in model membranes and to correlate this with the selective effect of hinokitiol on cells. To reach this goal, the toxicity of hinokitiol was evaluated using keratinocyte and fibroblast cell lines, and studies were performed on lipid monolayers (both one component and mixed systems). During investigations the surface pressure - area measurements, penetration studies and Brewster angle microscopy experiments were done. The analysis of the parameters calculated from the experimental data and the comparison of BAM images evidenced that, at membrane - related surface pressure, hinokitiol does not insert into model keratinocyte and fibroblast membranes and its impact on these systems is very weak. This important conclusion correlates with the in vitro experiments. The results for one component systems evidenced that the effect of hinokitiol on mammalian lipid films depends on the monolayer organisation and the lipid structure (especially the lipid polar head). In consequence, the type and proportion of lipids determines the effect of hinokitiol on the mixed films. The latter corroborates with the differences in the influence of hinokitiol on bacteria compared to mammalian lipids. It was concluded that hinokitiol exhibits selective activity toward bacterial cells compared to mammalian cells and their corresponding model membranes. Thus, the predominance of hinokitiol's antibacterial properties over its toxicity to skin cells may therefore be related to interactions of this compound with membrane lipids.

摘要

扁柏酚(β-崖柏素)是一种用于化妆品的天然抗菌剂。本研究的目的是深入了解扁柏酚与模型膜中脂质的相互作用,并将其与扁柏酚对细胞的选择性作用相关联。为实现这一目标,使用角质形成细胞和成纤维细胞系评估了扁柏酚的毒性,并对脂质单层(单组分和混合体系)进行了研究。在研究过程中,进行了表面压力-面积测量、渗透研究和布鲁斯特角显微镜实验。对从实验数据计算出的参数进行分析,并比较布鲁斯特角显微镜图像,结果表明,在与膜相关的表面压力下,扁柏酚不会插入模型角质形成细胞和成纤维细胞膜中,其对这些体系的影响非常微弱。这一重要结论与体外实验相关。单组分体系的结果表明,扁柏酚对哺乳动物脂质膜的影响取决于单层结构和脂质结构(尤其是脂质极性头部)。因此,脂质的类型和比例决定了扁柏酚对混合膜的影响。这一点与扁柏酚对细菌和哺乳动物脂质影响的差异相佐证。得出的结论是,与哺乳动物细胞及其相应的模型膜相比,扁柏酚对细菌细胞具有选择性活性。因此,扁柏酚的抗菌特性优于其对皮肤细胞的毒性,这可能与该化合物与膜脂质的相互作用有关。

相似文献

1
Lipid membrane composition modulates Hinokitiol's effects on keratinocytes and fibroblasts.脂质膜成分调节扁柏酚对角质形成细胞和成纤维细胞的作用。
Chem Phys Lipids. 2025 Aug;270:105511. doi: 10.1016/j.chemphyslip.2025.105511. Epub 2025 Jun 11.
2
Searching for the role of membrane lipids in the mechanism of antibacterial effect of hinokitiol.探讨桧木醇抗菌作用机制中膜脂的作用。
Arch Biochem Biophys. 2024 Nov;761:110178. doi: 10.1016/j.abb.2024.110178. Epub 2024 Oct 10.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.圣安德鲁斯皮肤癌转诊延迟研究(StARDISC):一项关于角质形成细胞皮肤癌治疗时间、生长、侵袭性、英国皮肤科医师协会危险因素及切除充分性的研究。
Br J Dermatol. 2025 Jun 20;193(1):157-166. doi: 10.1093/bjd/ljaf097.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.